| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | denosumab (Prolia®) |
| Formulation | 60 mg solution for injection |
| Reference number | 107 |
| Indication | Treatment of bone loss associated with hormone ablation in men with prostate cancer at risk of fractures |
| Company | Amgen Ltd |
| BNF chapter | Endocrine system |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 10/02/2010 |